TY - JOUR
T1 - Primary cutaneous NK/T-cell lymphoma of nasal type
T2 - an age-related lymphoproliferative disease?
AU - Wu, Chun Chieh
AU - Takahashi, Emiko
AU - Asano, Naoko
AU - Miyata-Takata, Tomoko
AU - Takata, Katsuyoshi
AU - Furukawa, Katsuya
AU - Elsayed, Ahmed Ali
AU - Hu, Lei Ming
AU - Satou, Akira
AU - Kohno, Kei
AU - Kosugi, Hiroshi
AU - Ohashi, Kenichi
AU - Kinoshita, Tomohiro
AU - Nakamura, Shigeo
AU - Kato, Seiichi
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/10
Y1 - 2017/10
N2 - Among extranodal NK/T-cell lymphoma of nasal type (NKTL), the extranasal variant (ENKTL) is known to have a worse prognosis with advanced clinical stage than the nasal variant of NKTL. However, detailed clinicopathological features of the localized extranasal disease have not been well documented in English literature. Here, we described the clinicopathological profiles of 14 patients with stage I ENKTL, including 7 in the skin, 5 in the gastrointestinal tract, and 2 in the central nervous system, highlighting the distinctiveness of the first. The 7 primary cutaneous (PCNKTL) cases were characterized by an older onset age (median, 76 versus 53 years, P =.012) and a more favorable clinical course (P =.041) compared with 17 patients with stages II-IV ENKTL that showed cutaneous involvement. The skin lesions in the PCNKTL group were distributed in the face or neck (n = 4) and limbs (n = 3) but not the trunk, which was most frequently affected (60%, P =.017) in the latter group. Furthermore, the stage I cutaneous disease showed a female predominance (male-female, 2:5 versus 7:0; P =.021) and a significantly more favorable survival compared with the noncutaneous stage I ENKTL (P =.037). These results suggest that PCNKTL constitute a distinct subgroup in the nasal-type lymphoma spectrum.
AB - Among extranodal NK/T-cell lymphoma of nasal type (NKTL), the extranasal variant (ENKTL) is known to have a worse prognosis with advanced clinical stage than the nasal variant of NKTL. However, detailed clinicopathological features of the localized extranasal disease have not been well documented in English literature. Here, we described the clinicopathological profiles of 14 patients with stage I ENKTL, including 7 in the skin, 5 in the gastrointestinal tract, and 2 in the central nervous system, highlighting the distinctiveness of the first. The 7 primary cutaneous (PCNKTL) cases were characterized by an older onset age (median, 76 versus 53 years, P =.012) and a more favorable clinical course (P =.041) compared with 17 patients with stages II-IV ENKTL that showed cutaneous involvement. The skin lesions in the PCNKTL group were distributed in the face or neck (n = 4) and limbs (n = 3) but not the trunk, which was most frequently affected (60%, P =.017) in the latter group. Furthermore, the stage I cutaneous disease showed a female predominance (male-female, 2:5 versus 7:0; P =.021) and a significantly more favorable survival compared with the noncutaneous stage I ENKTL (P =.037). These results suggest that PCNKTL constitute a distinct subgroup in the nasal-type lymphoma spectrum.
KW - Age-related EBV-associated lymphoproliferative disorders
KW - Cytotoxic molecules
KW - Epstein-Barr virus
KW - Primary cutaneous NK/T-cell lymphoma, nasal type
KW - T-cell receptor phenotype
UR - http://www.scopus.com/inward/record.url?scp=85030771343&partnerID=8YFLogxK
U2 - 10.1016/j.humpath.2017.08.025
DO - 10.1016/j.humpath.2017.08.025
M3 - 学術論文
C2 - 28873353
AN - SCOPUS:85030771343
SN - 0046-8177
VL - 68
SP - 61
EP - 68
JO - Human Pathology
JF - Human Pathology
ER -